Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,7818 USD | +4,24% | -0,26% | -12,06% |
05/04 | ACHILLES THERAPEUTICS PLC : Chardan Research persiste à l'achat | ZM |
05/04 | ACHILLES THERAPEUTICS PLC : Piper Sandler n'est plus à l'achat | ZM |
Métier
Nombre d'employés: 210
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Sergio Quezada
FOU | Founder | 49 | 01/11/20 |
Karl Peggs
FOU | Founder | 57 | 01/11/20 |
Iraj Ali
CEO | Chief Executive Officer | 48 | 01/01/18 |
Robert Coutts
DFI | Director of Finance/CFO | 40 | 01/11/20 |
Edward Samuel
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/22 |
Shree Patel
COO | Chief Operating Officer | - | - |
James Taylor
PRN | Corporate Officer/Principal | - | 01/07/22 |
Tariq Ahmed
HRO | Human Resources Officer | - | 01/03/20 |
Daniel Hood
LAW | General Counsel | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Carsten Boess
BRD | Director/Board Member | 57 | 01/04/20 |
Edwin Moses
CHM | Chairman | 69 | - |
Director/Board Member | 69 | 04/05/22 | |
Michael Giordano
BRD | Director/Board Member | 66 | 01/09/18 |
Julie O'Neill
BRD | Director/Board Member | 58 | 03/05/21 |
Iraj Ali
CEO | Chief Executive Officer | 48 | 01/01/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 41 082 948 | 38 326 282 ( 93,29 %) | 0 | 93,29 % |
Coordonnées société
Achilles Therapeutics Plc
245 Hammersmith Road
W6 8PW, London
+44 20 8154 4600
http://www.achillestx.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-12,06% | 32,12 M | |
+0,67% | 42,4 Md | |
+44,30% | 40,04 Md | |
-6,20% | 28,31 Md | |
+6,55% | 24,94 Md | |
-21,66% | 18,96 Md | |
+29,96% | 12,3 Md | |
-1,57% | 11,95 Md | |
+16,03% | 11,32 Md | |
-4,80% | 11,55 Md |
- Bourse
- Actions
- Action ACHL
- Société Achilles Therapeutics plc